openPR Logo
Press release

Kidney Cancer Diagnostics Market 2018-2028 Shares, Trend and Growth Report

02-14-2019 11:36 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Kidney Cancer Diagnostics

Kidney Cancer Diagnostics

A new report published by Fact.MR estimates the global kidney cancer diagnostics market to exhibit an impressive expansion at during the forecast period 2017 to 2022. In terms of revenues, the global market for kidney cancer diagnostics will reach nearly US$ 700 Mn by 2022-end.

Kidney cancer is a type of cancer which starts in kidney cells. Two major types of kidney cancer include transitional cell carcinoma (TCC) and renal cell carcinoma (RCC). Different types of kidney cancer get developed in different ways which imply different long-term outcomes. This cancer originates in two principal locations of the kidney – the renal pelvis and the renal tubule.

Competition Tracking

Myriad Genetics Inc, NeoGenomics Laboratories, NanoString Technologies Inc., Sysmex Corporation, Rosetta Genomics, Illumina, Inc., Quest Diagnostics Incorporated, Roche Holding AG, Thermo Fisher Scientific Inc., and Abbott Laboratories are observed as key players in the global market for kidney cancer diagnostics.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=56

Targeted Systemic Therapies for Metastatic Kidney Cancer are Providing Significant Benefits to Survival and Progression

Over the past few years, the diagnosis and management of kidney cancer, or, renal cell carcinoma (RCC), have undergone tremendous transformations. A number of discoveries, studies, and trails are being taken in renal mass biopsy, minimally-invasive thermal ablation, and active surveillance, owing to the surge in diagnosis rate of small renal masses, usually in patients with high morbidity risks related to operative treatment. In addition, targeted systemic therapies associated with metastatic kidney cancer have replaced cytokine-based treatment, providing significant benefits to survival and progression. Recent trails and reviews have cemented the partial nephrectomy’s role as the standard diagnosis-based surgical management option for majority of low-stage masses, and roles of adrenalectomy and lymphadenectomy pertaining to nephrectomy. These incidences are estimated to augment growth of the global kidney cancer diagnostics market.

Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=56

Hospital-associated Labs will Remain Preferred for Kidney Cancer Diagnostics

On the basis of end-users, hospital-associated labs are estimated to remain preferred for kidney cancer diagnostics, accounting for the largest revenues by 2022-end. Independent diagnostic laboratories will continue to be the second most lucrative end-users in the global kidney cancer diagnostics market. In addition, cancer research institutes are expected to register the highest CAGR in the market through 2022.

Immunochemistry tests will continue to be sought-after for kidney cancer diagnostics, with revenues expected to reach US$ 351.8 Mn by 2022-end. This test type segment is projected to register the highest CAGR in the market through 2022, followed by complete blood count test.

Urine analysis will remain the second largest adopted tests for kidney cancer diagnostics across the globe. However, revenues from blood chemistry tests of kidney cancer diagnostics will continue to be lower as compared to rest of the test segments in the market.

North America to Remain the Largest Market for Kidney Cancer Diagnostics

In terms of revenues, North America is expected to remain the largest market for kidney cancer diagnostics, followed by Europe. However, kidney cancer diagnostics market in Europe will exhibit a comparatively higher CAGR than North America during the forecast period. In addition, Asia Pacific excluding Japan (APEJ) will continue to be the fastest expanding market for kidney cancer diagnostics through 2022.

Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=56

Table of Content Covered in the report are:

Chapter 1 Global Kidney Cancer Diagnostics Market - Executive Summary 13

Chapter 2 Global Kidney Cancer Diagnostics Market Overview 15
2.1 Introduction 15
2.1.1 Global Kidney Cancer Diagnostics Market Taxonomy 15
2.1.2 Global Kidney Cancer Diagnostics Market Definition 15
2.2 Global Kidney Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022 16
2.2.1 Global Kidney Cancer Diagnostics Market Y-o-Y Growth 16
2.3 Global Kidney Cancer Diagnostics Market Dynamics 16
2.3.1 Drivers 16
2.3.2 Restraints 17
2.3.3 Trends 17
2.4 Supply Chain 17
2.5 Epidemiology 17
2.6 List of Distributors 17
2.7 Average Pricing Analysis 18
2.8 Regulations 18
2.9 Key Participants Market Presence (Intensity Map) By Region 18

Access This Report @ https://www.factmr.com/checkout/56/S

Chapter 3 Global Kidney Cancer Diagnostics Market Analysis and Forecast By Test Type 19
3.1 Global Kidney Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022 19
3.1.1 Immunohistochemistry Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 19
3.1.1.1 Revenue (US$ Mn) Comparison, By Region 19
3.1.1.2 Market Share Comparison, By Region 21
3.1.1.3 Y-o-Y growth Comparison, By Region 21
3.1.2 Urine Analysis Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 22
3.1.2.1 Revenue (US$ Mn) Comparison, By Region 22
3.1.2.2 Market Share Comparison, By Region 24
3.1.2.3 Y-o-Y growth Comparison, By Region 24
3.1.3 Complete Blood Count Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 25
3.1.3.1 Revenue (US$ Mn) Comparison, By Region 25
3.1.3.2 Market Share Comparison, By Region 27
3.1.3.3 Y-o-Y growth Comparison, By Region 27
3.1.4 Blood Chemistry Test Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 28
3.1.4.1 Revenue (US$ Mn) Comparison, By Region 28
3.1.4.2 Market Share Comparison, By Region 30
3.1.4.3 Y-o-Y growth Comparison, By Region 30

Chapter 4 Global Kidney Cancer Diagnostics Market Analysis and Forecast By End User 32
4.1 Global Kidney Cancer Diagnostics Market Size and Forecast By End User, 2012-2022 32
4.1.1 Hospital Associated Labs Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 32
4.1.1.1 Revenue (US$ Mn) Comparison, By Region 32
4.1.1.2 Market Share Comparison, By Region 34
4.1.1.3 Y-o-Y growth Comparison, By Region 34
4.1.2 Independent Diagnostic Laboratories Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 35
4.1.2.1 Revenue (US$ Mn) Comparison, By Region 35
4.1.2.2 Market Share Comparison, By Region 37
4.1.2.3 Y-o-Y growth Comparison, By Region 37
4.1.3 Cancer Research Institutes Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 38
4.1.3.1 Revenue (US$ Mn) Comparison, By Region 38
4.1.3.2 Market Share Comparison, By Region 40
4.1.3.3 Y-o-Y growth Comparison, By Region 40
4.1.4 Others Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 41
4.1.4.1 Revenue (US$ Mn) Comparison, By Region 41
4.1.4.2 Market Share Comparison, By Region 43
4.1.4.3 Y-o-Y growth Comparison, By Region 43

Chapter 5 Global Kidney Cancer Diagnostics Market Analysis and Forecast By Indication 45
5.1 Global Kidney Cancer Diagnostics Market Size and Forecast By Indication, 2012-2022 45
5.1.1 Renal Cell Carcinoma Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 45
5.1.1.1 Revenue (US$ Mn) Comparison, By Region 45
5.1.1.2 Market Share Comparison, By Region 47
5.1.1.3 Y-o-Y growth Comparison, By Region 47
5.1.2 Transitional Cell Carcinoma Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 48
5.1.2.1 Revenue (US$ Mn) Comparison, By Region 48
5.1.2.2 Market Share Comparison, By Region 50
5.1.2.3 Y-o-Y growth Comparison, By Region 50
5.1.3 Wilms Tumor Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 51
5.1.3.1 Revenue (US$ Mn) Comparison, By Region 51
5.1.3.2 Market Share Comparison, By Region 53
5.1.3.3 Y-o-Y growth Comparison, By Region 53
5.1.4 Kidney Lymphoma Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 54
5.1.4.1 Revenue (US$ Mn) Comparison, By Region 54
5.1.4.2 Market Share Comparison, By Region 56
5.1.4.3 Y-o-Y growth Comparison, By Region 56
5.1.5 Kidney Sarcoma Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 57
5.1.5.1 Revenue (US$ Mn) Comparison, By Region 57
5.1.5.2 Market Share Comparison, By Region 59
5.1.5.3 Y-o-Y growth Comparison, By Region 59

Chapter 6 Global Kidney Cancer Diagnostics Market Analysis and Forecast By Region 61
6.1 Global Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 61
6.1.1 North America Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 61
6.1.1.1 Revenue (US$ Mn) Comparison, By Test Type 61
6.1.1.2 Revenue (US$ Mn) Comparison, By End User 63
6.1.1.3 Revenue (US$ Mn) Comparison, By Indication 65
6.1.2 Latin America Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 67
6.1.2.1 Revenue (US$ Mn) Comparison, By Test Type 67
6.1.2.2 Revenue (US$ Mn) Comparison, By End User 69
6.1.2.3 Revenue (US$ Mn) Comparison, By Indication 71
6.1.3 Europe Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 73
6.1.3.1 Revenue (US$ Mn) Comparison, By Test Type 73
6.1.3.2 Revenue (US$ Mn) Comparison, By End User 74
6.1.3.3 Revenue (US$ Mn) Comparison, By Indication 76
6.1.4 Japan Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 78
6.1.4.1 Revenue (US$ Mn) Comparison, By Test Type 78
6.1.4.2 Revenue (US$ Mn) Comparison, By End User 80
6.1.4.3 Revenue (US$ Mn) Comparison, By Indication 81
6.1.5 APEJ Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 83
6.1.5.1 Revenue (US$ Mn) Comparison, By Test Type 83
6.1.5.2 Revenue (US$ Mn) Comparison, By End User 85
6.1.5.3 Revenue (US$ Mn) Comparison, By Indication 87
6.1.6 MEA Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 89
6.1.6.1 Revenue (US$ Mn) Comparison, By Test Type 89
6.1.6.2 Revenue (US$ Mn) Comparison, By End User 91
6.1.6.3 Revenue (US$ Mn) Comparison, By Indication 92

Chapter 7 North America Kidney Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 95
7.1 US Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 95
7.1.1 Revenue (US$ Mn) Comparison, By Test Type 95
7.1.2 Revenue (US$ Mn) Comparison, By End User 96
7.1.3 Revenue (US$ Mn) Comparison, By Indication 97
7.2 Canada Kidney Cancer Diagnostics Market Size and Forecast, 2012-2022 98
7.2.1 Revenue (US$ Mn) Comparison, By Test Type 98
7.2.2 Revenue (US$ Mn) Comparison, By End User 99
7.2.3 Revenue (US$ Mn) Comparison, By Indication 100

And Continue....

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Kidney Cancer Diagnostics Market 2018-2028 Shares, Trend and Growth Report here

News-ID: 1588219 • Views:

More Releases from Fact.MR

Fumaric Acid Market Forecast CAGR of 6.8% Predicted for 2023-2033 with a US$ 969.0 Million
Fumaric Acid Market Forecast CAGR of 6.8% Predicted for 2023-2033 with a US$ 969 …
In 2023, the fumaric acid market (フマル酸市場) reached a value of US$ 501.9 million, with projections indicating a growth at a CAGR of 6.8% to attain US$ 969.0 million by 2033. Fumaric acid, a key component in various industries including food and beverage, pharmaceuticals, and chemicals, is witnessing a steady rise in demand due to its versatile applications. The growth of the fumaric acid market is primarily driven by the
Buffering Agents Market Set for 5.1% CAGR Through 2023-2033 with a US$ 226.8 Million
Buffering Agents Market Set for 5.1% CAGR Through 2023-2033 with a US$ 226.8 Mil …
The buffering agents market (緩衝剤市場) is projected to reach a valuation of US$ 226.8 million by 2033, with a compound annual growth rate (CAGR) of 5.1% from 2023 to 2033. In 2023, the industry was valued at US$ 137.9 million. The market for buffering agents is anticipated to witness significant growth driven by increased industrial applications, expansion in the pharmaceutical and healthcare sectors, and rising demand for processed food and beverages.
Patient Temperature Monitoring Market Overview: Reaching US$ 8.2 Billion by 2026
04-23-2024 | Health & Medicine
Fact.MR
Patient Temperature Monitoring Market Overview: Reaching US$ 8.2 Billion by 2026
According to Fact.MR, a market research and competitive intelligence provider, the Global Patient Temperature Monitoring Market is predicted to reach a size of US$ 8.2 billion by 2026, rising at a CAGR of 10% from 2022 to 2026. a patient temperature monitor is a portable gadget that can measure temperature on its own for a brief amount of time. Opportunities for market participants will arise from the large patient pool
Surgical Equipment Market 8.6% CAGR: The Path to US$ 38.1 Billion By 2033
04-23-2024 | Health & Medicine
Fact.MR
Surgical Equipment Market 8.6% CAGR: The Path to US$ 38.1 Billion By 2033
Fact.MR's global Surgical Equipment Market research study provides a thorough examination of the top market segments according to application, region, business size, solution, and module. It also offers in-depth details on important participants and the primary strategies used to obtain an advantage over rivals. Fact.MR: A Supplier of Competitive Intelligence and Market Research: The surgical equipment market is expected to grow at a remarkable 8.6% CAGR over the following ten

All 5 Releases


More Releases for Comparison

FX-Toprebates.com - Trusted Broker Cashback Comparison
Altenglan - Forex trading is considered one of the best ways for average investors to make a decent and substantial profit even from small investments and a short period of time. Expansion of Forex trading in the market through new investors has significantly driven numerous established brokers to introduce certain programs that will encourage investors to make use of their services. Some of the common incentives involved are cashback and
Acephate Market - Strategies, Comparison, Shares 2023
Acephate is an organophosphate foliar insecticide sold as a soluble powder, as emulsifiable concentrates, as pressurized aerosol, and in tree injection systems and granular formulations. It is basically an insecticide made of esters of phosphoric acid. It is used primarily for control of aphids, including resistant species, in vegetables such as carrots, potatoes, tomatoes and lettuce. Acephate is an organophosphate insecticide. It is used on food crops, citrus trees, as
Moneybrag.com Offers Reliable Financial Comparison Services
Moneybrag.com is a leading online firm that specializes in online comparison services that enable clients to make comparisons of utility and personal finance products. Their primary goal is to provide information in an understandable format that allows for initial comparisons to be made at a glance. This enables customers to make healthy financial decisions. Moneybrag.com gives customers the ability to compare side by side and select a vendor based on
Comparison of Time recording applications
With hiring remote staff and freelancers halfway around the world turning into further common, it is necessary to look out the only thanks to keep track of the hours they work. Not entirely are you able to would like to know the hours to be able to pay them at the tip of the month but together notice an easy due to manage the invoices of an entire team. If
EInsuranceEz.com Launches Health Insurance Comparison Portal
EInsuranceEz.com, the online insurance price comparison company, launched a brand new customer-focused website this month. The site, einsuranceez.com, is designed to offer customers a wide range of competitively-priced life insurance, health insurance and auto insurance quotes instantly online. Working with some of the US biggest providers, EInsuranceEz.com constantly compares the best deals and insurance rates on the market to ensure that the customer gets the greatest saving for them. The company VP
PriceForSure.com - Benefits of Comparison Shopping
Comparison Shopping websites are beneficial to consumers and merchants because they offer a number of benefits. ( EMAILWIRE.COM, June 20, 2007 ) Rincon, Georgia – PriceForSure.com (www.PriceForSure.com) announces the benefits of comparison shopping. This informative and often entertaining form of shopping makes it easier for consumers to find the best deals on the web. Consumers search for products that they are interested in by comparing product types, product features,